Previsión
El precio objetivo medio de los analistas es de 10,63 € (+114,31 %). La mediana es de 9,11 € (+83,67 %).
| Comprar |
6 |
| Mantener |
1 |
| Vender |
0 |
Debates en la comunidad
Todavía no hay ninguna discusión sobre este activo.
Iniciar debateNoticias Ir al feed de noticias
Butterfly Network jumps sharply after Needham buy recommendation and $10 price target
Butterfly Network develops portable ultrasound systems such as the iQ3 that enable whole-body diagnostics via smartphone and AI-assisted image analysis. On September 22, Needham’s “Buy” rating and $10 price target, together with accelerated adoption of the company’s own AI platform, triggered a massive surge in the share price. The company continues to focus on miniaturization and AI to scale usage in hospitals and care settings. » Más en finanzen.net
Butterfly Network licenses ultrasound-chip technology to Merge Labs for brain-computer interfaces
Butterfly Network has signed a multi-year license agreement with Merge Labs that gives Merge access to the Poseidon family of Ultrasound-on-Chip technology through Butterfly Embedded, Butterfly’s licensing business. Merge Labs plans to use the semiconductor-based ultrasound platform to develop ultrasound-enabled brain-computer interfaces. The agreement includes upfront and milestone payments, hardware purchase commitments, and ongoing royalties on future revenues; Butterfly will be the exclusive partner for Merge’s CMOS‑MEMS chip‑based ultrasound technology but reserves the right to grant additional licenses. » Más en de.investing.com
Butterfly Network hits 52-week high at $9.74
The stock of Butterfly Network rose to a 52-week high of $9.74 and is currently trading around $9.77, implying a market capitalization of about $2.57 billion and a 1-year performance of +601.47%. Data from InvestingPro view the stock as significantly above its fair value and point to a high beta of 2.08, indicating considerable volatility. In Q2 2026 the company reported adjusted EPS of -$0.01 (better than expected) on revenue of $15.72 million (below expectations), but raised its full-year outlook and highlighted a record quarter with stronger margins and higher US sales. » Más en de.investing.com
Butterfly Network advances ultrasound revolution with chip and expanding software platform
Butterfly Network replaces traditional ultrasound crystals with a low-cost silicon microchip, transforming medical imaging. The company is shifting from a hardware provider to a platform, with cloud and AI software revenues already making up more than 40% of sales. A planned push into at-home patient monitoring from late 2026 is expected to open large future markets, but the stock remains speculative. » Más en finanzen.net
Butterfly Network comments on Midjourney full‑body ultrasound scanner and outlines hardware role
Butterfly Network said the prototype Midjourney scanner integrates 40 Ultrasound‑on‑Chip modules and future versions will scale to many more. CEO Joseph DeVivo described the system as a whole‑body scanner using roughly half a million sensors and over two petaflops of processing power, operating without radiation or magnetic risk and designed for frequent monitoring. Butterfly signaled commercial potential in Midjourney's roadmap and noted a prior co‑development agreement that could yield up to $74 million in payments over five years. » Más en finance.yahoo.com
Datos financieros
En el último trimestre, Butterfly Network tuvo unos ingresos de 28,78 M € y un beneficio neto de -11,31 M €
| (EUR) | septiembre de 2026 | YoY |
|---|---|---|
| Ingresos | 28,78 M | 57,17 % |
| Beneficio bruto | 21,01 M | 756,38 % |
| Beneficio neto | -11,31 M | 60,94 % |
| EBITDA | -9,63 M | 64,33 % |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1337,12 M € |
Número de acciones | 267,46 M |
Máximo/mínimo de 52 semanas | 9,30 € - 2,12 € |
| Dividendos | No |
Beta | 2,12 |
Ratio P/E | -26,22 |
Ratio PEG | -0,59 |
Ratio P/B | 7,93 |
Ratio P/S | 11,91 |
Perfil de la empresa
Butterfly Network, Inc., una empresa de salud digital, desarrolla, fabrica y comercializa soluciones de imagen por ultrasonido en Estados Unidos y a nivel internacional. Ofrece Butterfly iQ, un sistema de ultrasonido portátil de cuerpo entero con una sola sonda; Butterfly iQ+, un dispositivo de imagen por ultrasonido en el punto de atención que se conecta con un teléfono inteligente, una tableta y el sistema informático del hospital; y Butterfly Blueprint, una plataforma de ultrasonido para todo el sistema con el software Compass, que se integra en la infraestructura clínica y administrativa de un sistema sanitario. La empresa también proporciona el sistema Butterfly, que incluye sondas, así como accesorios relacionados y suscripciones de software, a sistemas sanitarios, médicos y proveedores de atención médica a través de una fuerza de ventas directa, distribuidores y un canal de comercio electrónico. Además, ofrece soluciones de software basadas en la nube para sistemas sanitarios, teleguía, tutoriales educativos dentro de la aplicación y programas de formación formal a través de su software Butterfly Academy, así como soporte y servicios clínicos. Butterfly Network, Inc. se constituyó en 2011 y tiene su sede en Guilford, Connecticut.
| Nombre | Butterfly Network |
| CEO | Joseph DeVivo |
| Sede | Burlington,
ma Estados Unidos |
| Sitio web | |
| Sector | Salud |
| Industria | Equipos y suministros sanitarios |
| Salida a bolsa | 13/07/2020 |
| Empleados | 220 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NYSE | BFLY |